Study To Estimate The Relative Bioavailability of Ertugliflozin (PF-04971729, MK-8835) in Healthy Adult Participants (MK-8835-039)

NCT01114568 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ertugliflozin 10 mg tablet
DRUG: Ertugliflozin OC Fast
DRUG: Ertugliflozin OC Slow

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]